Which Neuroprotective Agents are Ready for Bench to Bedside Translation in the Newborn Infant?
Open Access
- 30 April 2012
- journal article
- review article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 160 (4), 544-552.e4
- https://doi.org/10.1016/j.jpeds.2011.12.052
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Synergistic neuroprotective therapies with hypothermiaSeminars in Fetal and Neonatal Medicine, 2010
- Tetrahydrobiopterin as a Novel Therapeutic Intervention for AutismNeurotherapeutics, 2010
- Anesthetic Sevoflurane Causes Neurotoxicity Differently in Neonatal Naïve and Alzheimer Disease Transgenic MiceAnesthesiology, 2010
- “Control” laboratory rodents are metabolically morbid: Why it mattersProceedings of the National Academy of Sciences of the United States of America, 2010
- Tetrahydrobiopterin in the prevention of hypertonia in hypoxic fetal brainAnnals of Neurology, 2009
- The Common Inhalational Anesthetic Sevoflurane Induces Apoptosis and Increases β-Amyloid Protein LevelsArchives of Neurology, 2009
- Selective neuronal nitric oxide synthase inhibitors and the prevention of cerebral palsyAnnals of Neurology, 2009
- Discovery of Highly Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase by Fragment HoppingJournal of Medicinal Chemistry, 2009
- Acetylcysteine for Acetaminophen PoisoningThe New England Journal of Medicine, 2008
- Minimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase InhibitorsJournal of the American Chemical Society, 2008